Ajooni Biotech Ltd
Incorporated in 2010, Ajooni Biotech Ltd is a PURE VEG. animal health care solutions company. It is a significant player in the animal feed and aquaculture sectors.[1]
- Market Cap ₹ 134 Cr.
- Current Price ₹ 7.79
- High / Low ₹ 10.3 / 4.19
- Stock P/E 55.0
- Book Value ₹ 5.00
- Dividend Yield 0.00 %
- ROCE 7.76 %
- ROE 5.12 %
- Face Value ₹ 2.00
Pros
- Company has reduced debt.
- Company is almost debt free.
- Debtor days have improved from 76.0 to 59.1 days.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding is low: 26.9%
- Company has a low return on equity of 4.97% over last 3 years.
- Earnings include an other income of Rs.2.18 Cr.
- Promoter holding has decreased over last 3 years: -25.7%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: FMCG Industry: Food - Processing - Indian
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2012 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.57 | 7.21 | 13.23 | 28.53 | 42.28 | 39.65 | 40.03 | 50.82 | 74.04 | 74.48 | 80.00 | 91.01 | |
0.00 | 0.56 | 7.08 | 13.00 | 27.86 | 41.35 | 38.97 | 38.79 | 49.18 | 70.96 | 71.71 | 77.76 | 88.34 | |
Operating Profit | 0.00 | 0.01 | 0.13 | 0.23 | 0.67 | 0.93 | 0.68 | 1.24 | 1.64 | 3.08 | 2.77 | 2.24 | 2.67 |
OPM % | 1.75% | 1.80% | 1.74% | 2.35% | 2.20% | 1.72% | 3.10% | 3.23% | 4.16% | 3.72% | 2.80% | 2.93% | |
0.00 | 0.00 | 0.01 | 0.00 | 0.05 | 0.22 | 0.34 | 0.06 | 0.02 | 0.03 | 0.29 | 2.19 | 2.18 | |
Interest | 0.00 | 0.00 | 0.00 | 0.02 | 0.14 | 0.35 | 0.11 | 0.33 | 0.58 | 0.54 | 0.48 | 0.56 | 0.44 |
Depreciation | 0.00 | 0.00 | 0.03 | 0.07 | 0.19 | 0.31 | 0.44 | 0.49 | 0.58 | 1.11 | 1.00 | 0.87 | 0.90 |
Profit before tax | 0.00 | 0.01 | 0.11 | 0.14 | 0.39 | 0.49 | 0.47 | 0.48 | 0.50 | 1.46 | 1.58 | 3.00 | 3.51 |
Tax % | 0.00% | 27.27% | 28.57% | 28.21% | 20.41% | 14.89% | 29.17% | 26.00% | 28.08% | 28.48% | 28.00% | ||
0.00 | 0.01 | 0.07 | 0.10 | 0.28 | 0.39 | 0.41 | 0.35 | 0.37 | 1.05 | 1.12 | 2.16 | 2.44 | |
EPS in Rs | 0.02 | 0.12 | 0.18 | 0.36 | 0.03 | 0.03 | 0.02 | 0.02 | 0.05 | 0.06 | 0.12 | 0.15 | |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 64% |
5 Years: | 15% |
3 Years: | 16% |
TTM: | -1% |
Compounded Profit Growth | |
---|---|
10 Years: | 71% |
5 Years: | 39% |
3 Years: | 80% |
TTM: | 68% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 31% |
3 Years: | -19% |
1 Year: | 80% |
Return on Equity | |
---|---|
10 Years: | 5% |
5 Years: | 4% |
3 Years: | 5% |
Last Year: | 5% |
Balance Sheet
Figures in Rs. Crores
Mar 2012 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 0.01 | 0.24 | 0.24 | 0.24 | 0.33 | 5.86 | 6.16 | 8.41 | 10.01 | 10.01 | 17.52 | 17.52 | 34.45 |
Reserves | 0.00 | 0.12 | 0.19 | 0.29 | 0.64 | 5.09 | 6.01 | 7.49 | 5.65 | 6.38 | 24.15 | 25.19 | 51.68 |
0.00 | 0.00 | 0.00 | 0.78 | 0.62 | 4.68 | 4.77 | 5.02 | 6.78 | 5.35 | 5.18 | 2.17 | 2.20 | |
0.00 | 0.14 | 1.19 | 1.12 | 11.26 | 3.68 | 1.31 | 2.15 | 5.58 | 7.27 | 11.88 | 2.65 | 0.77 | |
Total Liabilities | 0.01 | 0.50 | 1.62 | 2.43 | 12.85 | 19.31 | 18.25 | 23.07 | 28.02 | 29.01 | 58.73 | 47.53 | 89.10 |
0.00 | 0.01 | 0.20 | 0.30 | 1.14 | 1.04 | 1.02 | 2.07 | 5.16 | 6.21 | 6.29 | 10.32 | 9.94 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.26 | 0.92 | 1.07 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 5.71 | 6.02 | 3.76 | 3.08 | 1.15 | 0.70 | 3.74 | 2.14 | 4.34 |
0.01 | 0.49 | 1.42 | 2.13 | 6.00 | 12.25 | 13.47 | 17.92 | 21.71 | 22.10 | 48.44 | 34.15 | 73.75 | |
Total Assets | 0.01 | 0.50 | 1.62 | 2.43 | 12.85 | 19.31 | 18.25 | 23.07 | 28.02 | 29.01 | 58.73 | 47.53 | 89.10 |
Cash Flows
Figures in Rs. Crores
Mar 2012 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.17 | -0.62 | -2.96 | -2.64 | -4.92 | -4.38 | 1.16 | 3.68 | -5.58 | -3.95 | ||
0.00 | -0.23 | -0.17 | -2.38 | -0.46 | 1.42 | 0.47 | -3.41 | -1.90 | -15.82 | 7.64 | ||
0.00 | 0.10 | 0.73 | 5.36 | 8.30 | -1.06 | 3.30 | 2.37 | -1.97 | 21.66 | -3.57 | ||
Net Cash Flow | 0.00 | 0.04 | -0.06 | 0.02 | 5.20 | -4.57 | -0.61 | 0.12 | -0.19 | 0.25 | 0.12 |
Ratios
Figures in Rs. Crores
Mar 2012 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 57.63 | 39.99 | 33.38 | 16.63 | 24.69 | 44.46 | 115.25 | 98.47 | 68.23 | 100.71 | 59.13 | |
Inventory Days | 141.02 | 22.39 | 13.62 | 63.23 | 19.37 | 50.74 | 34.39 | 45.65 | 33.53 | 38.81 | 79.74 | |
Days Payable | 99.55 | 65.91 | 26.90 | 78.66 | 9.01 | 11.61 | 20.17 | 45.82 | 38.78 | 56.13 | 8.20 | |
Cash Conversion Cycle | 99.11 | -3.53 | 20.10 | 1.20 | 35.06 | 83.59 | 129.47 | 98.30 | 62.98 | 83.39 | 130.68 | |
Working Capital Days | 96.05 | 4.56 | 9.38 | -29.43 | 35.39 | 90.03 | 138.23 | 112.04 | 71.88 | 110.66 | 134.05 | |
ROCE % | 0.00% | 27.85% | 18.39% | 36.55% | 9.64% | 3.56% | 4.44% | 4.98% | 9.10% | 6.01% | 7.76% |
Documents
Announcements
-
Press Release
18 November 2024 - Ajooni Biotech Limited has informed regarding a press release dated November 18, 2024, titled "Ajooni Biotech Reports Strong Q2 FY25 Result With Growth Of 52% …
-
Statement of deviation(s) or variation(s) under Reg. 32
13 November 2024 - Ajooni Biotech Limited has informed about statement of deviation(s) or variation(s) under Reg. 32
-
Financial Result Updates
13 November 2024 - Ajooni Biotech Limited has submitted to the Exchange, the financial results for the period ended September 30, 2024.
-
Outcome of Board Meeting
13 November 2024 - Ajooni Biotech Limited has informed regarding Board meeting held on November 13, 2024.
-
Board Meeting Intimation
4 November 2024 - AJOONI BIOTECH LIMITED has informed about Board Meeting to be held on 13-Nov-2024 to inter-alia consider and approve the Unaudited Financial results of the Company …
Business Overview:[1]
ABL was incorporated in February 2010 and was promoted by Mr Jasjot Singh (chairman and managing director). It manufactures a variety of compound animal feed such as cattle feed, cattle feed chips, camel feed, cotton oil cake, mustard oil cake and a wide range of feed supplements. Facilities in Khanna, Punjab, have a total installed capacity of 60,000 MTPA.